ARS Pharmaceuticals, Inc.SPRYNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-211.30%
↑ 99% vs avg
Percentile
P43
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-28508.08%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -211.30% | -6170.8% |
| 2024 | -3.37% | +100.0% |
| 2023 | -224823.33% | -8306.0% |
| 2022 | -2674.54% | -665.3% |
| 2021 | -349.46% | -13361.2% |
| 2020 | -2.60% | - |
| 2019 | 0.00% | - |
| 2018 | 0.00% | - |